Skip to content
healthcare.dev

ZEGFROVY

NDC 84694-102, Sunvozertinib, tablet, film coated, from Dizal Pharmaceutical Co., Ltd..

Product NDC
84694-102
Status
Listed
Labeler
Dizal Pharmaceutical Co., Ltd.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219839
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84694-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SUNVOZERTINIB200 mg/1
Package NDCNDC-11Package
84694-102-01846940102011 BOTTLE in 1 CARTON (84694-102-01) / 30 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/349fa84e-1fdb-4976-b1bb-689b80eac8ad

Use it

Look up 84694-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84694-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84694-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.